Position in DHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,904,840
-$20,597,612 QoQ
Shares Held
20,500
-80.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#689
of 2,098 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ARMISTICE CAPITAL, LLC holds $125,866,829 across 7 Diagnostics & Research names. DHR ranks #5 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
122,480 | $61,406,572 | |
| 2 | WAT |
Waters Corp /De/
|
75,004 | $28,129,500 | |
| 3 | ILMN |
Illumina, Inc.
|
91,118 | $16,021,277 | |
| 4 | TWST |
Twist Bioscience Corp
|
142,000 | $14,608,960 | |
| 5 | DHR |
Danaher Corp /De/
This page
|
20,500 | $3,904,840 | |
| 6 | A |
Agilent Technologies, Inc.
|
11,982 | $1,591,569 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
900 | $204,111 |
All Filings in DHR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,904,840 | 20,500 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $24,502,452 | 107,035 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,256,689 | 31,558 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $5,791,675 | 29,319 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,603,360 | 80,992 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||